In the quest to cure Alzheimer's, the protein known as beta-amyloid has long taken center stage, driving development of a ...

Stopping Alzheimer’s may begin with dissolving tiny tau protein clusters before damage takes hold.

Alzheimer’s disease has long been characterized primarily by the buildup of two proteins in the brain: beta-amyloid and tau. Decades of focus on beta-amyloid has failed to significantly help patients.

Researchers at UC San Francisco have identified a hazardous waste collector in the brain that disposes of the toxic clumps of ...

Tau protein aggregation is a shared feature in over 20 neurodegenerative diseases (collectively referred to as "tauopathies"). New research led by Boston Children's Hospital challenges the current ...

Researchers found a "garbage man" enzyme that tags toxic clumps of proteins in the brain for removal, and saw a correlation ...

Researchers have discovered that newborns have high levels of the tau protein, which is elevated in older people with Alzheimer’s disease, but that it causes them no harm. The discovery opens the door ...

A biomarker test identified tau pathology in Alzheimer's disease before fibrillary tangles developed. Neurofibrillary tangle formation can be prevented by targeting intermediate soluble tau assemblies ...